Tuesday, June 16, 2015

New Flu Drug Gives Your Body More Time To Defend Itself

 Cynthia Goldsmith, Centers for Disease Control and Prevention

Flu Virion

This negative-stained transmission electron micrograph (TEM) depicts the ultrastructural details of an influenza virus particle, or virion.

Dying from the flu can be a lot like drowning. As it progresses, the influenza virus affects the cellular barrier between the circulatory and respiratory systems, allowing other bodily fluids to leak into the lungs and causing them to fail. In the past, flu-fighting drugs have targeted the virus itself. But a new drug called Vasculotide reinforces the cellular barrier in the lungs, giving the body more time to rid itself of the virus. Astudy about the new drug was published recently in Scientific Reports.

Flu shots contain cells of the flu strain that researchers anticipate to be the one going around that year. When they’re right, vaccines work pretty well, provided that enough people get them well before they contract the virus. But if researchers are wrong, the vaccines could lead to viral resistance, maybe even resulting in a more virulent strain that could have devastating effects on the population. Since Vasculotide just treats the flu’s most life-threatening symptom, it doesn’t increase viral resistance.

Plus, Vasculotide works, at least in initial studies done in mice. The researchers infected two species of mice with lethal doses of three strains of the flu. After 48-72 hours, they weren’t looking so good—their body weight declined and they showed signs of hypothermia, all typical for having the flu—the researchers gave them Vasculotide. And it worked: 70 percent of the mice that received the drug after 72 hours survived.

Vasculotide is inexpensive to produce and is chemically stable, the researchers note. But a big part of the drug’s draw, as Michael Byrne notes in a piece for Motherboard, is that it doesn’t affect or “boost” the immune system. It merely buys the body some time to rid itself of the flu. And that could make all the difference.

About the Author

Prejeesh Sreedharan

Author & Editor

I am a Biotechnologist very much interested in #SciTech (Science And Technology). I closely follow the developments in medical science and life science. I am also very enthusiast in the world of electronics, information technology and robotics. I always looks for ways to make complicated things simpler. And I always believes simplest thing is the most complicated ones.


  1. Hope the new flu drugs could prevent new virus strains developing resistance and help to control future pandemics. Medicinal Chemistry


Hi-Tech Talk © 2015 - Designed by Templateism.com